Form 6-K Legend Biotech Corp For: Aug 19
|
LEGEND BIOTECH CORPORATION
|
|
|
|
|
Date: August 19, 2022
|
By:
|
/s/ Ying Huang
|
|
Name:
|
Ying Huang, Ph.D.
|
|
Title:
|
Chief Executive Officer
|
Legend Biotech Announces Participation in Upcoming Investor Conferences
SOMERSET, N.J.--(BUSINESS WIRE)--August 19, 2022--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:
Event: Citi's 17th Annual BioPharma Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Wednesday, September 7, 2022 at 11:20am ET
Presenter: Ying Huang, Ph.D., CEO
Event: 2022 Wells Fargo Healthcare Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Thursday, September 8, 2022 at 2:35pm ET
Presenter: Ying Huang, Ph.D., CEO
Event: Morgan Stanley Global Healthcare Conference 2022
Location: New York, New York
Fireside Chat Date & Time: Monday, September 12, 2022 at 3:40pm ET
Presenter: Ying Huang, Ph.D., CEO
Event: Jefferies Cell and Genetic Medicine Summit
Location: New York, New York
Date: September 29 & 30, 2022
About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.
Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.
Contacts
Investor Contacts:
Joanne Choi, Senior Manager, Investor Relations, Legend Biotech
[email protected]
Crystal Chen, Manager, Investor Relations, Legend Biotech
[email protected]
Press Contact:
Tina Carter, Corporate Communications Lead, Legend Biotech
[email protected]
(908) 331-5025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Legend Biotech (LEGN) Reports CARVYKTI Approved in EU
- New Exhibition 'Global Travelers' by Carole A. Feuerman: Master of Superrealism
- Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, Industry Recognition
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!